• 32952 Citations
1984 …2027
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1984 2019

Filter
Article
2015
78 Citations (Scopus)

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer

Ng, K., Meyerhardt, J. A., Chan, A. T., Sato, K., Chan, J. A., Niedzwiecki, D., Saltz, L. B., Mayer, R. J., Benson III, A. B., Schaefer, P. L., Whittom, R., Hantel, A., Goldberg, R. M., Venook, A. P., Ogino, S., Giovannucci, E. L. & Fuchs, C. S., Jan 1 2015, In : Journal of the National Cancer Institute. 107, 1

Research output: Contribution to journalArticle

Cyclooxygenase 2 Inhibitors
Colonic Neoplasms
Aspirin
Confidence Intervals
Disease-Free Survival
12 Citations (Scopus)

Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers

Manne, S., Kashy, D., Albrecht, T., Wong, Y. N., Lederman Flamm, A., Benson III, A. B., Miller, S. M., Fleisher, L., Buzaglo, J., Roach, N., Katz, M., Ross, E., Collins, M., Poole, D., Raivitch, S., Miller, D. M., Kinzy, T. G., Liu, T. & Meropol, N. J., Jan 1 2015, In : European Journal of Cancer Care. 24, 1, p. 28-38 11 p.

Research output: Contribution to journalArticle

Statistical Factor Analysis
Clinical Trials
Patient Participation
Neoplasms
Demography
23 Citations (Scopus)

Coffee intake, recurrence, and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Hu, F. B., Ogino, S., Wu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & 1 others, Fuchs, C. S., Nov 1 2015, In : Journal of Clinical Oncology. 33, 31, p. 3598-3607 10 p.

Research output: Contribution to journalArticle

Coffee
Colonic Neoplasms
Recurrence
Mortality
Tea
84 Citations (Scopus)

Minimally invasive esophagectomy: Results of a prospective phase II multicenter trial-The eastern cooperative oncology group (E2202) study

Luketich, J. D., Pennathur, A., Franchetti, Y., Catalano, P. J., Swanson, S., Sugarbaker, D. J., De Hoyos, A., Maddaus, M. A., Nguyen, N. T., Benson III, A. B. & Fernando, H. C., Apr 1 2015, In : Annals of surgery. 261, 4, p. 702-707 6 p.

Research output: Contribution to journalArticle

Esophagectomy
Multicenter Studies
Mortality
Esophageal Neoplasms
Length of Stay
171 Citations (Scopus)

Neuroendocrine tumors, version 1.2015

Kulke, M. H., Shah, M. H., Benson III, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., Emerson, L., Engstrom, P. F., Fanta, P., Giordano, T., Goldner, W. S., Halfdanarson, T. R., Heslin, M. J., Kandeel, F., Kunz, P. L., Kuvshinoff, B. W., Lieu, C., Moley, J. F., Munene, G., Pillarisetty, V. G. & 8 others, Saltz, L., Sosa, J. A., Strosberg, J. R., Vauthey, J. N., Wolfgang, C., Yao, J. C., Burns, J. & Freedman-Cass, D., Jan 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 1, p. 78-108 31 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Practice Guidelines
Thymus Gland
Gastrointestinal Tract
Pancreas
25 Citations (Scopus)
oxaliplatin
Leucovorin
Rectal Neoplasms
Fluorouracil
Radiation
120 Citations (Scopus)

Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

Benson, A. B., Venook, A. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fenton, M. J., Fuchs, C. S., Grem, J. L., Grothey, A., Hochster, H. S., Hunt, S., Kamel, A., Kirilcuk, N., Leong, L. A., Lin, E., Messersmith, W. A., Mulcahy, M. F. & 14 others, Murphy, J. D., Nurkin, S., Rohren, E., Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Gregory, K. M. & Freedman-Cass, D., Jun 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 6, p. 719-728 10 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Guidelines
Primary Care Physicians
Publications
Survival Rate
25 Citations (Scopus)

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Argilés, G., Saunders, M. P., Rivera, F., Sobrero, A., Benson III, A. B., Guillén Ponce, C., Cascinu, S., Van Cutsem, E., MacPherson, I. R., Strumberg, D., Köhne, C. H., Zalcberg, J., Wagner, A., Luigi Garosi, V., Grunert, J., Tabernero, J. & Ciardiello, F., May 1 2015, In : European Journal of Cancer. 51, 8, p. 942-949 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Disease-Free Survival
Survival
regorafenib
6 Citations (Scopus)

Survival following early-stage colon cancer: An ACCENT-based comparison of patients versus a matched international general population

for the Adjuvant Colon Cancer Endpoints (ACCENT) Group, May 1 2015, In : Annals of Oncology. 26, 5, p. 950-958 9 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Survival
Population
oxaliplatin
Recurrence
5 Citations (Scopus)

Young age and aggressive treatment in colon cancer

Berian, J. R., Benson III, A. B. & Nelson, H., Aug 11 2015, In : JAMA - Journal of the American Medical Association. 314, 6, p. 613-614 2 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Young Adult
Drug Therapy
Colon
Survival
2016
31 Citations (Scopus)

90Y radioembolization of colorectal hepatic metastases using glass microspheres: Safety and survival outcomes from a 531-patient multicenter study

Hickey, R. M., Lewandowski, R. J., Prudhomme, T., Ehrenwald, E., Baigorri, B., Critchfield, J., Kallini, J., Gabr, A., Gorodetski, B., Geschwind, J. F., Abbott, A., Shridhar, R., White, S. B., Rilling, W. S., Boyer, B., Kauffman, S., Kwan, S., Padia, S. A., Gates, V. L., Mulcahy, M. F. & 4 others, Kircher, S. M., Nimeiri, H. S., Benson III, A. B. & Salem, R., May 1 2016, In : Journal of Nuclear Medicine. 57, 5, p. 665-671 7 p.

Research output: Contribution to journalArticle

Eye Protective Devices
Microspheres
Multicenter Studies
Neoplasm Metastasis
Survival
7 Citations (Scopus)

Adjusted hospital sentinel lymph node positivity rates in melanoma a novel potential measure of quality

Kinnier, C. V., Paruch, J. L., Dahlke, A. R., Wayne, J. D., Benson III, A. B., Winchester, D. P. & Bilimoria, K. Y., Jan 1 2016, In : Annals of surgery. 263, 2, p. 392-398 7 p.

Research output: Contribution to journalArticle

Sentinel Lymph Node Biopsy
Melanoma
Survival
Sentinel Lymph Node
Odds Ratio
6 Citations (Scopus)

BATON-CRC: A phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer

Benson III, A. B., Kiss, I., Bridgewater, J., Eskens, F. A. L. M., Sasse, C., Vossen, S., Chen, J., Van Sant, C., Ball, H. A., Keating, A. & Krivoshik, A., Oct 15 2016, In : Clinical Cancer Research. 22, 20, p. 5058-5067 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Disease-Free Survival
Neuropilin-1
Medical Futility
Biomarkers
37 Citations (Scopus)

CALGB 80403 (Alliance)/E1206: A randomized phase II study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal Junction Cancers

Enzinger, P. C., Burtness, B. A., Niedzwiecki, D., Ye, X., Douglas, K., Ilson, D. H., Villaflor, V. M., Cohen, S. J., Mayer, R. J., Venook, A., Benson, A. B. & Goldberg, R. M., Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2736-2742 7 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
irinotecan
Cisplatin
Drug Therapy
Epirubicin
6 Citations (Scopus)

Care for a patient with cancer as a project: Management of complex task interdependence in cancer care delivery

Trosman, J. R., Carlos, R. C., Simon, M. A., Madden, D. L., Gradishar, W. J., Benson, A. B., Rapkin, B. D., Weiss, E. S., Gareen, I. F., Wagner, L. I., Khan, S. A., Bunce, M. M., Small, A. & Weldon, C. B., Nov 1 2016, In : Journal of oncology practice. 12, 11, p. 1101-1113 13 p.

Research output: Contribution to journalArticle

Patient Care
Neoplasms
Quality of Health Care
Ataxia
Outcome Assessment (Health Care)
6 Citations (Scopus)
irinotecan
radiology
Radiology
Cisplatin
radiation therapy
710 Citations (Scopus)

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J. Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V. & 27 others, Hoff, P., Köhne, C. H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., österlund, P., Oyen, W. J. G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T. J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H. J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A. & Arnold, D., Aug 1 2016, In : Annals of Oncology. 27, 8, p. 1386-1422 37 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Guidelines
Therapeutics
Neoplasms
11 Citations (Scopus)

Financial concerns about participation in clinical trials among patients with cancer

Wong, Y. N., Schluchter, M. D., Albrecht, T. L., Benson III, A. B., Buzaglo, J., Collins, M., Flamm, A. L., Fleisher, L., Katz, M., Kinzy, T. G., Liu, T. M., Manne, S., Margevicius, S., Miller, D. M., Miller, S. M., Poole, D., Raivitch, S., Roach, N., Ross, E. & Meropol, N. J., Feb 10 2016, In : Journal of Clinical Oncology. 34, 5, p. 479-487 9 p.

Research output: Contribution to journalArticle

Clinical Trials
Decision Making
Neoplasms
Self Efficacy
Health Care Costs
34 Citations (Scopus)
Bilirubin
Liver Neoplasms
Albumins
Hepatocellular Carcinoma
Survival
112 Citations (Scopus)

Locally advanced, unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline

Balaban, E. P., Mangu, P. B., Khorana, A. A., Shah, M. A., Mukherjee, S., Crane, C. H., Javle, M. M., Eads, J. R., Allen, P., Ko, A. H., Engebretson, A., Herman, J. M., Strickler, J. H., Benson, A. B., Urba, S. & Yee, N. S., Aug 1 2016, In : Journal of Clinical Oncology. 34, 22, p. 2654-2667 14 p.

Research output: Contribution to journalArticle

Medical Oncology
Pancreatic Neoplasms
Practice Guidelines
Comorbidity
oxaliplatin
8 Citations (Scopus)

Neoadjuvant therapy for rectal cancer affects lymph node yield and status without clear implications on outcome: The case for eliminating a metric and using preoperative staging to guide therapy

Abdel-Misih, S. R. Z., Wei, L., Benson III, A. B., Cohen, S., Lai, L., Skibber, J., Wilkinson, N., Weiser, M., Schrag, D. & Bekaii-Saab, T., Dec 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 12, p. 1528-1534 7 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Rectal Neoplasms
Lymph Nodes
Survival
Drug Therapy
4 Citations (Scopus)

Precision Medicine and Pancreatic Cancer

Farrell, J. J., Moughan, J., Wong, J. L., Regine, W. F., Schaefer, P., Benson III, A. B., Macdonald, J. S., Liu, X., Yen, Y., Lai, R., Zheng, Z., Bepler, G., Guha, C. & Elsaleh, H., Nov 1 2016, In : Pancreas. 45, 10, p. 1485-1493 9 p.

Research output: Contribution to journalArticle

gemcitabine
Precision Medicine
Pancreatic Neoplasms
Deoxycytidine Kinase
Radiation Oncology
13 Citations (Scopus)
oxaliplatin
Peripheral Nervous System Diseases
Neoplasms
Hot Temperature
Skin
9 Citations (Scopus)

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

Burtness, B., Powell, M., Catalano, P., Berlin, J., Liles, D. K., Chapman, A. E., Mitchell, E. & Benson III, A. B., Aug 1 2016, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 39, 4, p. 340-345 6 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Pancreatic Neoplasms
Disease-Free Survival
Enoxaparin
18 Citations (Scopus)

Randomized trial of a web-based intervention to address barriers to clinical trials

Meropol, N. J., Wong, Y. N., Albrecht, T., Manne, S., Miller, S. M., Flamm, A. L., Benson, A. B., Buzaglo, J., Collins, M., Egleston, B., Fleisher, L., Katz, M., Kinzy, T. G., Liu, T. M., Margevicius, S., Miller, D. M., Poole, D., Roach, N., Ross, E. & Schluchter, M. D., Feb 10 2016, In : Journal of Clinical Oncology. 34, 5, p. 469-478 10 p.

Research output: Contribution to journalArticle

Clinical Trials
Education
National Cancer Institute (U.S.)
Decision Making
Patient Education
7 Citations (Scopus)
Hepatocellular Carcinoma
Survival
Liver Neoplasms
Pharmaceutical Preparations
Drug Therapy
122 Citations (Scopus)
Yttrium
Carcinoma
Hepatocellular Carcinoma
Liver Neoplasms
Confidence Intervals
2017
20 Citations (Scopus)

A blueprint to advance colorectal cancer immunotherapies

Le, D. T., Hubbard-Lucey, V. M., Morse, M. A., Heery, C. R., Dwyer, A., Marsilje, T. H., Brodsky, A. N., Chan, E., Deming, D. A., Diaz, L. A., Fridman, W. H., Goldberg, R. M., Hamilton, S. R., Housseau, F., Jaffee, E. M., Kang, S. P., Krishnamurthi, S. S., Lieu, C. H., Messersmith, W., Sears, C. L. & 10 others, Segal, N. H., Yang, A., Moss, R. A., Cha, E., O'Donnell-Tormey, J., Roach, N., Davis, A. Q., McAbee, K., Worrall, S. & Benson III, A. B., Nov 1 2017, In : Cancer Immunology Research. 5, 11, p. 942-949 8 p.

Research output: Contribution to journalArticle

Immunotherapy
Colorectal Neoplasms
Microsatellite Repeats
T-Lymphocytes
Biomarkers
3 Citations (Scopus)

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

Bleiberg, H., Decoster, G., de Gramont, A., Rougier, P., Sobrero, A., Benson III, A. B., Chibaudel, B., Douillard, J. Y., Eng, C., Fuchs, C., Fujii, M., Labianca, R., Larsen, A. K., Mitchell, E., Schmoll, H. J., Sprumont, D. & Zalcberg, J., May 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 922-930 9 p.

Research output: Contribution to journalArticle

Consent Forms
Informed Consent
Clinical Trials
Documentation
Neoplasms
13 Citations (Scopus)

A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the Second-Line treatment of metastatic KRAS mutant colorectal adenocarcinoma

Randolph Hecht, J., Benson, A. B., Vyushkov, D., Yang, Y., Bendell, J. & Verma, U., Mar 1 2017, In : Oncologist. 22, 3

Research output: Contribution to journalArticle

Colorectal Neoplasms
Adenocarcinoma
Placebos
irinotecan
Disease-Free Survival
15 Citations (Scopus)

A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma

Benson, A. B., Wainberg, Z. A., Randolph Hecht, J., Vyushkov, D., Dong, H., Bendell, J. & Kudrik, F., Mar 1 2017, In : Oncologist. 22, 3

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Placebos
Therapeutics
Disease-Free Survival
22 Citations (Scopus)

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Garg, M. K., Zhao, F., Sparano, J. A., Palefsky, J., Whittington, R., Mitchell, E. P., Mulcahy, M. F., Armstrong, K. I., Nabbout, N. H., Kalnicki, S., El-Rayes, B. F., Onitilo, A. A., Moriarty, D. J., Fitzgerald, T. J. & Benson, A. B., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 718-726 9 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Radiology
Anal Canal
Squamous Cell Carcinoma
Papillomaviridae
5 Citations (Scopus)

Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors

Ayyagari, R., Neary, M., Li, S., Rokito, A., Yang, H., Xie, J. & Benson, A. B., Nov 1 2017, In : American Health and Drug Benefits. 10, 8, p. 408-415 8 p.

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Health Care Costs
Costs and Cost Analysis
Drug Costs
1 Citation (Scopus)

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR

Huynh, L., Totev, T., Vekeman, F., Neary, M. P., Duh, M. S. & Benson III, A. B., Sep 2 2017, In : Journal of Medical Economics. 20, 9, p. 945-951 7 p.

Research output: Contribution to journalArticle

Octreotide
Carcinoid Tumor
Diarrhea
Neuroendocrine Tumors
Costs and Cost Analysis
167 Citations (Scopus)

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer a randomized clinical trial

Venook, A. P., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., Berry, S., Polite, B. N., O'Reilly, E. M., Goldberg, R. M., Hochster, H. S., Schilsky, R. L., Bertagnolli, M. M., El-Khoueiry, A. B., Watson, P., Benson III, A. B. & 3 others, Mulkerin, D. L., Mayer, R. J. & Blanke, C., Jun 20 2017, In : JAMA - Journal of the American Medical Association. 317, 23, p. 2392-2401 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Randomized Controlled Trials
Drug Therapy
Survival
oxaliplatin
65 Citations (Scopus)

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Bartley, A. N., Washington, M. K., Colasacco, C., Ventura, C. B., Ismaila, N., Benson III, A. B., Carrato, A., Gulley, M. L., Jain, D., Kakar, S., Mackay, H. J., Streutker, C., Tang, L., Troxell, M. & Ajani, J. A., Feb 1 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 4, p. 446-464 19 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Guidelines
TYK2 Kinase
Clinical Decision-Making
Pathologists
11 Citations (Scopus)

Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver

Su, Y. K., Mackey, R. V., Riaz, A., Gates, V. L., Benson III, A. B., Miller, F. H., Yaghmai, V., Gabr, A., Salem, R. & Lewandowski, R. J., Nov 1 2017, In : Journal of Vascular and Interventional Radiology. 28, 11, p. 1520-1526 7 p.

Research output: Contribution to journalArticle

Yttrium
Neuroendocrine Tumors
Liver
Fibrosis
Therapeutics
524 Citations (Scopus)

Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors

Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., Bushnell, D., O'Dorisio, T. M., Baum, R. P., Kulkarni, H. R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A. & 15 others, Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, K., Sierra, M. L., Santoro, P., Thevenet, T., Erion, J. L., Ruszniewski, P., Kwekkeboom, D. & Krenning, E., Jan 12 2017, In : New England Journal of Medicine. 376, 2, p. 125-135 11 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Octreotide
Survival Analysis
Control Groups
Disease-Free Survival
14 Citations (Scopus)

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

Fuchs, M. A., Yuan, C., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Innocenti, F., Warren, R. S., Bertagnolli, M. M., Ogino, S., Giovannucci, E. L. & 3 others, Horvath, E., Meyerhardt, J. A. & Ng, K., Jun 1 2017, In : Annals of Oncology. 28, 6, p. 1359-1367 9 p., mdx109.

Research output: Contribution to journalArticle

Vitamin D
Colonic Neoplasms
Recurrence
Mortality
Survival
4 Citations (Scopus)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis

Benson III, A. B., Broder, M. S., Cai, B., Chang, E., Neary, M. P. & Papoyan, E., Sep 7 2017, In : World Journal of Gastroenterology. 23, 33, p. 6128-6136 9 p.

Research output: Contribution to journalArticle

Insurance Claim Review
Neuroendocrine Tumors
Databases
Somatostatin
Therapeutics
2018
3 Citations (Scopus)

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Berlin, J. D., Feng, Y., Catalano, P., Abbruzzese, J. L., Philip, P. A., McWilliams, R. R., Lowy, A. M., Benson, A. B. & Blackstock, A. W., Jan 1 2018, In : Oncology (Switzerland). 94, 1, p. 39-46 8 p.

Research output: Contribution to journalArticle

gemcitabine
Research
Neoplasms
Disease-Free Survival
Therapeutics
5 Citations (Scopus)

A Phase II Study of Celecoxib with Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Previously Untreated Advanced or Metastatic Colorectal Cancer

Chen, E. Y., Blanke, C. D., Haller, D. G., Benson III, A. B., Dragovich, T., Lenz, H. J., Robles, C., Li, H., Mori, M., Mattek, N., Sanborn, R. E. & Lopez, C. D., Dec 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 12, p. 1193-1198 6 p.

Research output: Contribution to journalArticle

irinotecan
Celecoxib
Leucovorin
Fluorouracil
Colorectal Neoplasms
16 Citations (Scopus)

Association of survival with adherence to the American cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis the calgb 89803/alliance trial

Van Blarigan, E. L., Fuchs, C. S., Niedzwiecki, D., Zhang, S., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Giovannucci, E. L., Ng, K. & Meyerhardt, J. A., Jun 1 2018, In : JAMA Oncology. 4, 6, p. 783-790 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Survivors
Guidelines
Exercise
Confidence Intervals

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Zhang, S., Niedzwiecki, D., Li, Y., Babic, A., Morales-Oyarvide, V., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Zoltick, E. S., Stampfer, M., Ng, K. & 5 others, Wu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & Fuchs, C. S., Jul 1 2018, In : PloS one. 13, 7, e0199244.

Research output: Contribution to journalArticle

Beverages
relapse
colorectal neoplasms
Colonic Neoplasms
beverages
1 Citation (Scopus)

Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance)

Van Blarigan, E. L., Ou, F. S., Niedzwiecki, D., Zhang, S., Fuchs, C. S., Saltz, L., Mayer, R. J., Venook, A., Ogino, S., Song, M., Benson III, A. B., Hantel, A., Atkins, J. N., Giovannucci, E. L. & Meyerhardt, J. A., Oct 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 10, p. 1227-1230 4 p.

Research output: Contribution to journalArticle

Dietary Fats
Colonic Neoplasms
Recurrence
Survival
Vegetables
2 Citations (Scopus)

E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors

Lubner, S., Feng, Y., Mulcahy, M. F., O'Dwyer, P., Giang, G. Y., Hinshaw, J. L., Deming, D., Klein, L., Teitelbaum, U., Payne, J., Engstrom, P., Stella, P., Meropol, N. & Benson III, A. B., Sep 1 2018, In : Oncologist. 23, 9, p. 1006-e104

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Disease-Free Survival
Vascular Endothelial Growth Factor A
Fatigue
2 Citations (Scopus)

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

Broder, M. S., Cai, B., Chang, E., Yan, T. & Benson III, A. B., Aug 3 2018, In : Journal of Medical Economics. 21, 8, p. 821-826 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Delivery of Health Care
Costs and Cost Analysis
Somatostatin
Drug Therapy
1 Citation (Scopus)

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing

Trosman, J. R., Weldon, C. B., Gradishar, W. J., Benson III, A. B., Cristofanilli, M., Kurian, A. W., Ford, J. M., Balch, A., Watkins, J. & Phillips, K. A., Sep 1 2018, In : Value in Health. 21, 9, p. 1062-1068 7 p.

Research output: Contribution to journalArticle

Insurance Carriers
Neoplasms
Medicare
Technology
Precision Medicine
25 Citations (Scopus)

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

Salem, R., Gabr, A., Riaz, A., Mora, R., Ali, R., Abecassis, M., Hickey, R., Kulik, L., Ganger, D., Flamm, S., Atassi, R., Atassi, B., Sato, K., Benson, A. B., Mulcahy, M. F., Abouchaleh, N., Asadi, A. A., Desai, K., Thornburg, B., Vouche, M. & 7 others, Habib, A., Caicedo, J., Miller, F. H., Yaghmai, V., Kallini, J. R., Mouli, S. & Lewandowski, R. J., Oct 2018, In : Hepatology. 68, 4, p. 1429-1440 12 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Hepatocellular Carcinoma
Confidence Intervals
Survival
Therapeutics
2 Citations (Scopus)
Yttrium
Microspheres
Glass
Hepatocellular Carcinoma
Randomized Controlled Trials